RAUDER
This release updates the previous release that posted earlier on Tuesday 6, 2024 to add more information.
PANAMA CITY, PANAMA / ACCESSWIRE / February 8, 2024 / The forum focused on promoting public health policies based on human rights and scientific evidence.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.• Panels addressed the need for legal access to reduced-risk alternatives, such as electronic cigarettes, for millions of smokers.
• Forum's participants signed a manifesto calling on COP10 delegates to avoid prohibition and look at scientific evidence and consumers' perspectives.
Razón Autonomía Derecho A.C, RAUDER, a non-profit civil association that advocates for human rights, personal autonomy, and the free development of personality, organized the "2nd Latin American Nicotine and Risk Reduction Forum: Science, Regulation, and Activism" that took place today in Panama City. The objective was to analyze and discuss the crucial role of reduced-risk alternatives in the fight against tobacco.
The event brought together legislators, experts, doctors, scientists, and activists from across the globe. They emphasized the importance of developing public policies that aim towards harm reduction and respect for human rights, and called for a humane and effective approach, that respects consumers' rights and provides safe, science-based regulated options.
They shared different perspectives around studies and relevant practices from various countries on how alternatives such as vapor products can significantly contribute to harm reduction in smoking. Participants emphasized that their prohibition in countries such as Mexico, Brazil and Panama, has led to an increase in illegal trade and limits smokers' options to access safer alternatives.
"It is essential to recognize and regulate vapor products as reduced-risk alternatives. Prohibition not only prevents smokers from legal options but drives the black market, and gives easier access to minors, besides, all the other negative consequences that it implies," explained Rafael Lara Liy, RAUDER's director.
Doctor Marina Hoyo, a forum's panelist, said: "As health professionals, we have a responsibility to stay up to date, analyze, understand, and question the evidence. But we also need to approach our patient care from a position of empathy towards people seeking to improve their health. That's why we must consider alternatives that reduce risks. This is the foundation of a therapeutic bond that aims to truly help the individual and not stigmatize them, but rather try to alleviate their condition."
Víctor Manuel Salcedo, member of the Chamber of Representatives of Colombia, explained: "Whenever there is a health risk, regulation is necessary. We, as legislators, have the responsibility to act immediately. Our experience indicates that we should regulate, but not prohibit."
The case of other countries, such as Brazil, was also discussed. In Brazil, the ban on vapor products since 2009 has led to an uncontrolled and unsanitary illegal market, affecting millions of smokers, according to Juan José Cirión Lee, President of the organization "México y el Mundo Vapeando." We urge the Brazilian National Health Surveillance Agency (ANVISA) not to miss the opportunity to regulate alternative nicotine consumption products, considering their potential for risk reduction and respect for human rights," he added.
Studies show a significant reduction in smoking rates through reduced-risk alternatives. "The results of studies in Sweden are a clear example of what can be achieved with reduced-risk alternatives. In just 15 years, Sweden has reduced its smoking rates from 15% to 5.6% and has achieved a mortality rate from tobacco-related diseases 39.6% lower than the EU average. This success is attributed to the accessibility, acceptability, and affordability of safer alternatives, combined with balanced regulations and awareness campaigns," explained Roberto Sussman, Researcher at the UNAM Institute of Nuclear Sciences in Mexico.
RAUDER has created an online petition to strengthen the collective voice in defense of human rights, health, and legal access to nicotine alternatives. Those interested in signing the petition or supporting the cause can do so by visiting the dedicated space on the Change.org platform.
The event ended with a manifest that demands all Latin American governments to avoid prohibitions and develop science-based regulatory frameworks. "Our goal is to ensure that smokers have access to less harmful alternatives as part of a comprehensive strategy to reduce the impact of smoking on public health and that our voices are heard. This perspective is especially relevant in the context of the Tenth Conference of the Parties to the WHO Framework Convention on Tobacco Control (COP 10), taking place this week in Panama," added Rafael Lara, Director of RAUDER.
"It is important to emphasize that we share the fundamental goal of protecting public health. We advocate for the voices of consumers to be considered in discussions and decision-making that significantly impact their human rights and global health," Lara emphasized.
About RAUDER
RAUDER, short for Razón, Autonomía y Derecho, A.C., is a non-profit organization composed of experts in various fields of knowledge. Their mission is to promote and defend human rights and their respect in the daily life of society. The organization aims to influence society and public policies with the banner of respect for human rights in all aspects of social development, providing citizens with clarity about which rights they can assert concerning their governing authorities.
PRESS CONTACT:
Abroad: alejandro@nimbus.mx
Contact Information
ALEJANDRO DURAN
PR DIRECTOR
alejandro@nimbus.mx
+525534467248
SOURCE: RAUDER
To view this piece of content from stats.newswire.com, please give your consent at the top of this page.View the original press release on newswire.com.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Clean Air Metals Announces 2026 Strategic Objectives in Historically Strong PGE and Copper Markets13.1.2026 01:10:00 CET | Press release
THUNDER BAY, ON / ACCESS Newswire / January 12, 2026 / Clean Air Metals Inc. ("Clean Air Metals" or the "Company") (TSXV:AIR)(FRA:CKU0(OTCQB:CLRMF) is pleased to provide an overview of its 2026 objectives and highlights of 2025, for its 100%-owned Thunder Bay North ("TBN") Critical Minerals Project in Northwestern Ontario. Critical Project Advancement Objectives Spot prices for platinum, copper and palladium have appreciated by 70% (1000 $/oz), 25% (1.20 $/lb) and 50% 624($/oz) respectively versus study prices, since the results of the Preliminary Economic Assessment (PEA) were announced in the October 9th release. Using the financial model published in the PEA and applying current spot metal prices (as of January 6th), the TBN project shows a $708M1 NPV8 and a pre-tax IRR of 100% (post-tax NPV8 = $494M1 and IRR = 84%).This is a significant improvement in the project outlook in comparison to the PEA results that featured a $219.4M2 pre-tax NPV8 and a pre-tax IRR of 39%. This year, cons
Germany Buys Eight MQ-9B SeaGuardian(R) RPA Through NSPA12.1.2026 20:00:00 CET | Press release
NSPA Supports NATO Countries in the Acquisition and Sustainment of GA-ASI's Advanced Multi-Domain RPA SAN DIEGO, CALIFORNIA / ACCESS Newswire / January 12, 2026 / Germany's Federal Office of Bundeswehr Equipment, Information Technology and In-Service Support and the NATO Support and Procurement Agency (NSPA) have announced the procurement of eight MQ-9B SeaGuardian® Remotely Piloted Aircraft (RPA) from General Atomics Aeronautical Systems, Inc. (GA-ASI). The program includes four Certifiable Ground Control Stations. First delivery is expected in 2028. Germany joins a growing list of NATO countries that have selected GA-ASI's advanced MQ-9B RPA for its multi-domain capabilities with exceptionally long range and endurance. The platform provides pole-to-pole satellite control and de-icing capabilities to enable missions in cold climates. SeaGuardian features two multi-mode surface-search radars that deliver wide-area maritime surveillance, with an option to add Anti-Submarine Warfare capa
Datavault AI Announces Target to Expand its AI Driven Data Monetization Network to Over 100 Cities Across the Contiguous United States, Starting in the Second Half of 2026 with Corresponding 2027 Revenue Target12.1.2026 14:05:00 CET | Press release
Datavault AI expects to have a fully operational network with over 100 nodes across 33 cities nationwide, generating revenue in the second half of 2026. Target revenue for this project is $400 to $500 million, thereby supporting the $200 million revenue guidance for 2026. With the full deployment of Datavault AI's nodes across 100+ cities throughout the United States, the 2027 revenue target is $2.0 to $3.0 billion for 2027. New York and Philadelphia edge network activation positions Datavault AI to potentially capture a significant share of the insurance and financial sectors, the healthcare industry, and enterprise opportunities. PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / January 12, 2026 / Datavault AI Inc. (Nasdaq:DVLT), a leader in AI-driven data valuation, monetization, credentialing, and digital engagement technologies, today highlighted the strategic importance of its New York and Philadelphia edge network deployment with Available Infrastructure's SanQtum AI platform. This
OBI Pharma and TegMine Therapeutics Sign Exclusive Global License Agreement for Glycan-Targeting ADC12.1.2026 13:00:00 CET | Press release
Successful Delivery of Commissioned ADC Candidate to Advance the Collaboration Between OBI and TegMine TAIPEI, TW / ACCESS Newswire / January 12, 2026 / OBI Pharma (4174.TWO) announced that it has entered into a commercial license agreement with TegMine Therapeutics, Inc. (TegMine), a San Francisco-based biopharma focused on developing antibodies targeting cancer-associated glycans and glycoproteins, for a glycan-targeting ADC. Under the terms of the agreement, OBI is eligible to receive an upfront payment as well as development and commercial milestones. Following product launch, OBI will also receive royalties based on a tiered percentage of annual net sales. While the detailed financial terms are not disclosed in accordance with the confidentiality provisions, the overall deal economics are broadly comparable to those of recent similar licensing transactions in the market. TegMine will obtain the exclusive global rights to develop and commercialize the ADC under the license agreemen
Charlie's Holdings (OTCQB:CHUC) Signs Agreement with IKE Tech to Commercialize Transformational Age-Gated Vapes that Will Address FDA Concerns Related to Youth Access12.1.2026 12:00:00 CET | Press release
SBX Product Line Will Feature First-Ever AI-Powered Blockchain-Based Age-Gating System for Vape Products IKE's patented biometric BLE Bluetooth chip and blockchain-based app will enable Charlie's to ensure that underage individuals will not be able to activate or utilize the Company's age-gated products. The IKE Licensing Agreement provides CHUC with a first mover advantage in youth access prevention (one of the FDA's top priorities) and a three-year exclusivity period for age-gated nicotine analogue products. Charlie's will test market the IKE age-gating system this spring with the Company's popular SBX nicotine analogue product line; simultaneously, Charlie's intends to incorporate the revolutionary technology into its PACHA branded Electronic Nicotine Delivery Systems (ENDS). COSTA MESA, CA / ACCESS Newswire / January 12, 2026 / Charlie's Holdings, Inc. (OTCQB:CHUC) ("Charlie's" or the "Company"), an industry leader in the premium vapor products space, today reported that the Compan
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
